
Baxter International Reports $2.7 Billion in Q1 Sales Amid 12% International Growth and Strategic Turnaround
Baxter International Inc.Description
What this story covers
Baxter International navigates a complex first quarter with 2 point 7 billion dollars in sales, balancing a 12 percent international surge against U.S. declines and manufacturing headwinds. The company reiterated its 2026 outlook, focusing on operational efficiency and new product safety innovations.
Story snapshot
CompanyBaxter International Inc.
TickerBAX
VariantStandard detailed
Duration5:44
Filing type8-K
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001628280-26-028582
Sources1
Full Story Script
Content not available for this story.